None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? MACS (Manual ability classification system) level II, III, IV , Cerebral Palsy or Static Brain injury (6 months after the onset) ? MHFC (Modified House Functional Classification) level 4,5,6,7 ? male or female, 3 to 17 years 11months ? Patients without cognitive impairment who are able to comply with protocol-required procedure ? Voluntarily agreed and singed the consent
Exclusion criteria
Exclusion criteria: ? Significant mental retardation, hard to apply study device ? Significant visual impairment, hard to recognize screen ? Skin/ Musculoskeletal deformity, hard to wear study device ? Etc, The subject who is deemed unsuitable for this study ? Botulinum toxin therapy in the study limb within 6 months prior to the baseline assessment day or History of treatment with alcohol block or orthopedic surgery in the study limb within 12 months prior to the baseline assessment day ? Severe dizziness or nausea and vomiting symptom during the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of Melbourne Assessment of Unilateral Upper Limb Function (MULL) | — |
Secondary
| Measure | Time frame |
|---|---|
| Kinematic data of computerized 3D motion analysis;Upper Limb Physician's Rating Scale (ULPRS);Pediatric Evaluation of Disability Inventory (PEDI);Side Effect or Adverse Event | — |
Countries
Korea, Republic of
Contacts
Eulji University Hospital